In lung cancer, TRIB2 blocks C/EBP-α activity by direct binding promoting the ubiquitination of C/EBP-α and consequently its proteasomal degradation through the interaction between the E3 ligase TRIM21 and the C-tail of TRIB2 [47]. The gene discussed is CEBPA; the disease is lung carcinoma.